accuRx, one of Europe’s fastest-growing healthcare platforms, has raised £27.5 million in Series B funding.
Its software is used by 98% of GP practices. The London company delivered a booking solution which has been used to help administer more than 21 million vaccinations to date, more than a quarter of all those delivered in England.
The round was led by Lakestar with participation from British Patient Capital, Latitude VS, Atomico, Trusted Insight and Encore Capital.
The funds will facilitate the growth of the accuRx team, enhancing its offering to GP practices and building products that will enable expansion into secondary care, with a growing number of hospitals and community trusts also using the platform to communicate with their patients and one another.
During the pandemic, accuRx introduced a video interface which facilitated remote consultations and surveys to allow remote monitoring of patients with COVID symptoms. Two million patients are now contacted via accuRx weekly.
“accuRx’s product has reinvigorated communication with our patients, enabling a better relationship between GPs and patients, which has ultimately led to better care provision,” said Dr David Triska, GP Partner at Witley and Milford Surgeries.
“Our patients now have the confidence that they’re getting speedy and accurate responses from our team, and the use of regular Florey questionnaires to gather more information from our patients has been transformative for clinical record keeping and the care we provide.”
Founded at Entrepreneur First, the company is now developing system-wide infrastructure that allows for NHS communication outside of GP systems, such as accuRx Web, which currently has 11,000 weekly active users in non-GP settings including hospitals, pharmacies and care homes.
“We believe that healthcare is a communication industry and when healthcare teams can communicate easily and reliably, they can deliver even better patient care,” said Jacob Haddad, CEO and co-founder of accuRx.
“We’re proud to have become a critical piece of infrastructure for general practice in the UK, and they’ve used us to message over 60% of the population.
“We’ve got an exciting roadmap to grow our adoption in settings like hospitals and district nursing, to connect communication across the health and care system.”
Oliver Heimes, partner at Lakestar, added: “An overhaul of communications in the healthcare industry is long overdue. Inefficient communication between nurses, doctors, general practitioners, to name a few, is tremendously detrimental to patients.
“We see this issue in healthcare sectors around the world and the pandemic has only heightened the need for action.
“We’re proud of what accuRx has been able to accomplish so far in transforming communication within primary care and we can’t wait to see the great benefits its tools will afford secondary care as well.
“With its product suite, accuRx has the potential to become a crucial backbone and infrastructure of healthcare markets globally.”